Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 15;7(1):14-24.
doi: 10.3945/an.115.009803. Print 2016 Jan.

Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications

Ana Gabriela Murillo  1 , Maria Luz Fernandez  2
Affiliations
Review

Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications

Ana Gabriela Murillo et al. Adv Nutr. .

Abstract

Diabetes is a chronic metabolic disease that affects a substantial part of the population around the world. Whether type I or type II, this disease has serious macro- and microvascular complications that constitute the primary cause of death in diabetic patients. Microvascular complications include diabetic retinopathy, nephropathy, and neuropathy. Although these complications are clinically and etiologically diverse, they share a common factor: glucose-induced damage. In the progression of diabetic complications, oxidative stress, inflammation, and the formation of glycation end products play an important role. Previous studies have shown that a healthy diet is vital in preventing these complications; in particular, the intake of antioxidants has been studied for their potential effect in ameliorating hyperglycemic injuries. Carotenoids are lipid-soluble pigments synthesized by plants, bacteria, and some kinds of algae that are responsible for the yellow, red, and orange colors in food. These compounds are part of the antioxidant machinery in plants and have also shown their efficacy in quenching free radicals, scavenging reactive oxygen species, modulating gene expression, and reducing inflammation in vitro and in vivo, showing that they can potentially be used as part of a preventive strategy for metabolic disorders, including diabetes and its related complications. This review highlights the potential protective effects of 4 non-provitamin A carotenoids--lutein, zeaxanthin, lycopene, and astaxanthin--in the development and progression of diabetic microvascular complications.

Keywords: carotenoids; diabetes; inflammation; microvascular complications; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: AG Murillo and ML Fernandez, no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Molecular structures of lycopene, astaxanthin, lutein, and zeaxanthin.
FIGURE 2
FIGURE 2
Proposed mechanisms by which non-provitamin A carotenoids may suppress glucose-induced damage and prevent microvascular complications in diabetes derived from cell and animal studies. Detrimental effects of hyperglycemia lead to microvascular complications in diabetes. High blood sugar causes oxidative stress, inflammation, and an uncontrolled production of advanced glycation products, all of which create a proinflammatory loop and cause the vascular permeability and dysfunction commonly seen in diabetic patients with retinopathy, nephropathy, or neuropathy. The carotenoids lutein, lycopene, zeaxanthin, and astaxanthin may ameliorate this glucose-induced damage by quenching free radicals, scavenging reactive oxygen species, blocking inflammatory pathways, AGE-RAGE engagement/signaling, and even decreasing plasma glucose concentrations. Arrows indicate a positive interaction, whereas bar-headed lines denote a blockage of a pathway or a decrease of a compound. Note that the mechanisms that are more strongly supported by the published evidence are shown with a dark arrow, whereas the ones shown with dotted lines represent weaker evidence. AGE, advanced glycation end product; ICAM, intercellular adhesion molecule 1; MDA, malondialdehyde; PVA, provitamin A; RAGE: receptor for advanced glycation end product; ROS, reactive oxygen species; VCAM-1, vascular adhesion protein 1; VEGF, vascular endothelial growth factor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38. - PubMed
    1. Dabla PK. Renal function in diabetic nephropathy. World J Diabetes 2010;1:48–56. - PMC - PubMed
    1. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005;59:365–73. - PubMed
    1. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J 2012;27:269–73. - PMC - PubMed
    1. Yang W, Dall TM, Halder P, Gallo P, Kowal SL, Hogan PF, Petersen M. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–46. - PMC - PubMed

MeSH terms

  NODES
Note 2
twitter 2